西罗莫司与血管紧张素转换酶抑制剂：一则警示 - Suppr

Sirolimus and ACE-inhibitors: a note of caution.

作者信息

Burdese Manuel, Rossetti Maura, Guarena Cesare, Consiglio Valentina, Mezza Elisabetta, Soragna Giorgio, Gai Massimo, Segoloni Giuseppe Paolo, Piccoli Giorgina Barbara

出版信息

Transplantation. 2005 Jan 27;79(2):251-2. doi: 10.1097/01.tp.0000140966.13047.85.

DOI:10.1097/01.tp.0000140966.13047.85

PMID:15665781

Abstract

摘要

相似文献

Sirolimus and ACE-inhibitors: a note of caution.

Transplantation. 2005 Jan 27;79(2):251-2. doi: 10.1097/01.tp.0000140966.13047.85.

Sirolimus and angiotensin-converting enzyme inhibitors together induce tongue oedema in renal transplant recipients.

Nephrol Dial Transplant. 2004 Nov;19(11):2906-8. doi: 10.1093/ndt/gfh352.

Proteinuria after conversion to sirolimus in kidney transplant recipients: impact of pre-existing proteinuria, graft function, and angiotensin-converting enzyme inhibitors/angiotensin-receptor antagonists.

Clin Transplant. 2010 Sep-Oct;24(5):626-30. doi: 10.1111/j.1399-0012.2009.01142.x.

The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.

Trials. 2015 Dec 19;16:581. doi: 10.1186/s13063-015-1100-8.

ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?

Blood Press. 2009;18(1-2):4-6. doi: 10.1080/08037050902742282.

[Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].

Dtsch Med Wochenschr. 2012 Nov;137(48):2498. doi: 10.1055/s-0032-1327303. Epub 2012 Nov 20.

Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.

Hypertension. 2007 Feb;49(2):276-84. doi: 10.1161/01.HYP.0000253780.36691.4f. Epub 2006 Dec 11.

Mechanisms and management of proteinuria in kidney transplant patients.

Drugs. 2008;68 Suppl 1:33-9. doi: 10.2165/00003495-200868001-00005.

Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?

Cerebrovasc Dis. 2008;26(5):563-4. doi: 10.1159/000164555. Epub 2008 Oct 21.

[New studies on hypertension of great significance to clinical practice. Also very old persons benefit from blood pressure reduction].

Lakartidningen. 2008;105(19):1382-4.

引用本文的文献

Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation.

Drug Saf. 2019 Jul;42(7):813-825. doi: 10.1007/s40264-019-00810-9.

Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4.

Clin J Am Soc Nephrol. 2016 May 6;11(5):785-794. doi: 10.2215/CJN.09900915. Epub 2016 Feb 22.

Oedema, solid organ transplantation and mammalian target of rapamycin inhibitor/proliferation signal inhibitors (mTOR-I/PSIs).

Clin Kidney J. 2014 Apr;7(2):115-20. doi: 10.1093/ckj/sfu001. Epub 2014 Feb 24.

Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients.

Clin J Am Soc Nephrol. 2010 Apr;5(4):703-8. doi: 10.2215/CJN.07371009. Epub 2010 Jan 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Sirolimus and ACE-inhibitors: a note of caution.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献